Search Clinical Trials
583,492 trials
ID
Status
Phase
Title
Sponsor
NCT07572266
Adjuvant Nitrate to Boost Exercise-induced Health Benefits in Older AdultsFlorida Institute for Human and Machine CognitionNot Yet RecruitingNot Applicable
NCT07572266Not Yet Recruiting
Not Applicable
Adjuvant Nitrate to Boost Exercise-induced Health Benefits in Older AdultsFlorida Institute for Hum...
NCT07573163
Tirzepatide Following Adrenalectomy in Mild Autonomous Cortisol SecretionAlaa SadaNot Yet RecruitingPhase 2
NCT07573163Not Yet Recruiting
Phase 2
Tirzepatide Following Adrenalectomy in Mild Autonomous Cortisol SecretionAlaa Sada
NCT07573878
Combined Effects of Neurodynamics With PNF on Pain and ROM in Patients With CTS.Riphah International UniversityCompletedNot Applicable
NCT07573878Completed
Not Applicable
Combined Effects of Neurodynamics With PNF on Pain and ROM in Patients With CTS.Riphah International Univ...
NCT07572032
Delayed Initiation of ARNI and SGLT2i in Heart Failure With Corrected Aetiology (DELAY-HF), Pilot StudyAjou University Medical CenterNot Yet RecruitingPhase 4
NCT07572032Not Yet Recruiting
Phase 4
Delayed Initiation of ARNI and SGLT2i in Heart Failure With Corrected Aetiology...Ajou University Medical C...
NCT07573540
Optimizing Smart Technology for Addiction RecoveryNational Institute on Alcohol Abuse and Alcoholism (NIAAA)Not Yet RecruitingNot Applicable
NCT07573540Not Yet Recruiting
Not Applicable
Optimizing Smart Technology for Addiction RecoveryNational Institute on Alc...
NCT07571954
Evaluation of iNstroke 5F Aspiration Catheters for Thrombectomy: a Multi-center Prospective StudyiVascular S.L.U.Not Yet RecruitingNot Applicable
NCT07571954Not Yet Recruiting
Not Applicable
Evaluation of iNstroke 5F Aspiration Catheters for Thrombectomy: a Multi-center...iVascular S.L.U.
NCT07573124
Efficacy of Combining Mulligan Spinal Mobilization With Leg Movement and Mechanical Lumbar Traction in Lumbar RadiculopathyKhyber Medical University PeshawarRecruitingNot Applicable
NCT07573124Recruiting
Not Applicable
Efficacy of Combining Mulligan Spinal Mobilization With Leg Movement and Mechani...Khyber Medical University...
NCT07572071
Safety and Feasibility of Bilateral Striatal Transplantation of DopaCell in Parkinson's DiseaseIran University of Medical SciencesRecruitingPhase 1
NCT07572071Recruiting
Phase 1
Safety and Feasibility of Bilateral Striatal Transplantation of DopaCell in Park...Iran University of Medica...
NCT07573670
A Phase 2 Study of Bcl-2 Inhibitor Combined With Azacitidine for Newly Diagnosed Mixed Phenotype Acute LeukemiaThe First Affiliated Hospital of Soochow UniversityNot Yet RecruitingPhase 2
NCT07573670Not Yet Recruiting
Phase 2
A Phase 2 Study of Bcl-2 Inhibitor Combined With Azacitidine for Newly Diagnosed...The First Affiliated Hosp...
NCT07571941
Effects of CO Level on Pain, Sensory Function, and Subjective HealthIzmir Democracy UniversityNot Yet Recruiting
NCT07571941Not Yet Recruiting
—
Effects of CO Level on Pain, Sensory Function, and Subjective HealthIzmir Democracy Universit...
NCT07573826
Effect of Pursed-Lip Breathing With Different I:E Ratios on Respiratory Outcomes in COPD PatientsScholastica Fina Aryu PuspasariNot Yet RecruitingNot Applicable
NCT07573826Not Yet Recruiting
Not Applicable
Effect of Pursed-Lip Breathing With Different I:E Ratios on Respiratory Outcomes...Scholastica Fina Aryu Pus...
NCT07573306
Validation and Feasibility of Noninvasive Oxygen Delivery Index Monitoring in Cardiac Surgery PatientsUniversity of MinnesotaNot Yet Recruiting
NCT07573306Not Yet Recruiting
—
Validation and Feasibility of Noninvasive Oxygen Delivery Index Monitoring in Ca...University of Minnesota
NCT07572383
Advanced Imaging to Assess the Effect of Immunosuppression on Progressive FibrosisNational Heart, Lung, and Blood Institute (NHLBI)RecruitingPhase 2
NCT07572383Recruiting
Phase 2
Advanced Imaging to Assess the Effect of Immunosuppression on Progressive Fibros...National Heart, Lung, and...
NCT07573059
Evaluation of the Safety of Loargys Arginine Test System in Loargys-treated PatientsImmedica Pharma US IncRecruitingNot Applicable
NCT07573059Recruiting
Not Applicable
Evaluation of the Safety of Loargys Arginine Test System in Loargys-treated Pati...Immedica Pharma US Inc
NCT07573748
Apple Vision Pro-Assisted Vascular Identification in Lung SurgeryThe Second People's Hospital of Huai'anNot Yet RecruitingNot Applicable
NCT07573748Not Yet Recruiting
Not Applicable
Apple Vision Pro-Assisted Vascular Identification in Lung SurgeryThe Second People's Hospi...
NCT07574333
Effects of Short and Long Courses of Intermittent Hypoxic-Hyperoxic Training in Patients With Type 2 Diabetes Including ElderlyNational Medical Research Center for Therapy and Preventive MedicineRecruitingNot Applicable
NCT07574333Recruiting
Not Applicable
Effects of Short and Long Courses of Intermittent Hypoxic-Hyperoxic Training in...National Medical Research...
NCT07572123
Evaluating the Addition of Maintenance Immunotherapy Compared to the Usual Treatment of Chemotherapy and Autologous Stem Cell Transplant Alone for High-risk Patients With Relapsed or Refractory Hodgkin LymphomaNational Cancer Institute (NCI)Not Yet RecruitingPhase 2
NCT07572123Not Yet Recruiting
Phase 2
Evaluating the Addition of Maintenance Immunotherapy Compared to the Usual Treat...National Cancer Institute...
NCT07574073
CD20 Monoclonal Antibody Combined With BTK Inhibitor for the Treatment of Refractory Immune-related CytopeniaQi dengNot Yet RecruitingPhase 1
NCT07574073Not Yet Recruiting
Phase 1
CD20 Monoclonal Antibody Combined With BTK Inhibitor for the Treatment of Refrac...Qi deng
NCT07573436
Loncastuximab Tesirine and Rituximab as First-line Therapy in Patients With Post-transplant Lymphoproliferative Disorder (PLUTO)ADC Therapeutics S.A.Not Yet RecruitingPhase 1
NCT07573436Not Yet Recruiting
Phase 1
Loncastuximab Tesirine and Rituximab as First-line Therapy in Patients With Post...ADC Therapeutics S.A.
Result Breakdown
Not yet recruiting14 (70%)
Recruiting5 (25%)
Completed1 (5%)
not_applicable10 (50%)
Phase 24 (20%)
Phase 13 (15%)
Not Specified2 (10%)
Phase 41 (5%)